Featuring perspectives from Dr Jeremy S Abramson, Dr John N
Allan, Dr Bita Fakhri, Dr Shuo Ma and Dr Mazyar Shadman, moderated
by Dr Abramson, including the following topics:
Introduction (0:00)
Current and Future Role of Continuous Bruton Tyrosine Kinase
(BTK) Inhibitor Therapy for Previously Untreated Chronic
Lymphocytic Leukemia (CLL) — Dr Fakhri (2:22)
Available and Emerging Approaches to Time-Limited Therapy for
Treatment-Naïve CLL — Dr Allan (23:24)
Optimal Management of Adverse Events with BTK and Bcl-2
Inhibitors; Considerations for Special Patient Populations — Dr Ma
(56:31)
Selection and Sequencing of Therapy for Relapsed/Refractory CLL
— Dr Shadman (1:17:01)
Chimeric Antigen Receptor T-Cell Therapy and Other Novel
Strategies for CLL — Dr Abramson (1:38:24)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.